ABSTRACT
Background: Despite the assumptions that people with disabilities are considered sexually inactive, this group of people is likely to engage in sexual risk behaviours. People with disabilities are the neglected group of population; investigating their sexual behaviour helps to design interventions by the local government and concerned bodies. Therefore, the aim of this study was to study the prevalence and factors associated with risky sexual behaviours among people with disabilities. Methods: Institutional based Cross-sectional study was conducted in 2013. All disabled individuals who were enrolled as a member of the disability associations in the city were included in the study. Data were collected by pre-tested structured interview questionnaires by trained data collectors. The data were coded, entered, cleaned and analyzed using univariate, bivariate and multivariate analysis with SPSS version 16 soft ware package. Results: About 301(73.1%) of the respondents were sexually debuted, of which 153(50.8%) were sexually debuted before the age of 18 years and 166(55.1%) reported that they have had more than one sexual partner in the last twelve months. Besides, 32.5% of the study participants reported to have risky sexual behaviours. The age of respondents was a statistically significant predictors of sexual behavior with [(AOR=1.5, 95%CI:0.88-2.57), (AOR=1.54, 95%CI:0.68-3.52) and (AOR=3.1, 95%CI:1.64-5.87)]. Drinking alcohol was another predictors of sexual behaviour where [(AOR=1.72, 95%CI:1.10-2.70)]. Besides educational status and family size were other significant predictors of risky sexual behaviour on multivariable logistic regression with [(AOR= 3.14, 95%CI:1.02- 9.74), AOR=6.31, 95%CI:1.78-22.31), AOR=3.30, 95%CI:1.13- 9.68), and AOR=3.28, 95%CI:1.07-10.10)] and [AOR=1.73, 95%CI:1.10-2.70)] respectively. Conclusion: People with disabilities were engaged in sexual risk behaviour. Age, alcohol use, educational status, and family size were significant predictors of risky sexual behaviours among people with disabilities on which interventions need to be done by concerned bodies on this vulnerable group of people, especially by labor and social affairs of Ethiopia.
ABSTRACT
Background: Assessment of antimicrobial use can be performed by evaluating their use. Drug use evaluation is a performance improvement method that focuses on evaluation and improvement of drug use processes to achieve optimal patient outcomes. The objective of this study was to evaluate the rational use of ceftriaxone in Medical ward of Dessie referral Hospital, Dessie-Ethiopia. Methods: Retrospective systematic study was used to assess rational use of ceftriaxone. The study was conducted by reviewing medication records of 316 patients, who received ceftriaxone during hospitalization at Medical ward of Dessie referral Hospital from December 30, 2011 to January, 2013. A systematic sampling method was used to select inpatient prescriptions in this ward with ceftriaxone and patient cards were located based on the medical record number on the prescription papers. Data was collected by using structured format and evaluated against WHO criteria for drug use evaluation as per standard treatment guideline of Ethiopia. Results: Most patients were dosed as 2 g/day (79.4%). The duration of therapy was found to be high in the range 2-7 days (51.69%). Ceftriaxone was mainly used as pneumonia treatment (38.8%). Maintenance fluids were the most commonly co-administered medications with a frequency of 62.16%. The use of ceftriaxone was appropriate only in 170 cases (55.8%) for the justification of use. Most of inappropriate uses were seen in terms of duration during treatment of pneumonia followed by frequency for the treatment of meningitis. Consistency of prescriber to the national standard treatment guideline was found to be low. Conclusions: To improve rational use and prevent the development of resistance; prescribers should adhere to the national standard treatment guideline. Intensification of short term trainings and antibiotic control systems are some of the possible solutions the hospital has to do.ceftriaxone therapy does not meet the current STG of Ethiopia.